We have previously demonstrated that modulating the activity of DNMT and HDAC proteins in prostate cancer cell lines and ex vivo human prostate tissue induced the expression of cancer testis antigens (CTAs), which have been proposed as targets for tumor vaccine therapies25. The gene discussed is DNMT1; the disease is prostate cancer.